Diadema Partners »

Biohaven shares owned by Diadema Partners

Quarter-by-quarter ownership of Biohaven (BHVN) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Biohaven

Tip: Access up to 7 years of quarterly data

All positions including Biohaven held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biohaven by Diadema Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $4.7M 317k 14.88
2026-03-31 $2.7M 317k 8.46
2025-12-31 $2.3M 200k 11.29

More positions owned by Diadema Partners

Abivax Sa Sponsored Ads Call Option (ABVX)
Viking Therapeutics (VKTX)
Bristol Myers Squibb Put Option (BMY)
Amgen Call Option (AMGN)
United Therapeutics Corporation (UTHR)
Revolution Medicines (RVMD)
Uniqure Nv SHS Put Option (QURE)
Novartis Sponsored Adr Call Option (NVS)
Kodiak Sciences Call Option (KOD)
Capricor Therapeutics Com New Put Option (CAPR)
Cogent Biosciences (COGT)
Bridgebio Pharma Note 1.750% 3/0 (Principal)
Corcept Therapeutics Incorporated Call Option (CORT)
BioMarin Pharmaceutical (BMRN)
Kymera Therapeutics Call Option (KYMR)

View all positions for Diadema Partners

Top funds holding Biohaven

Henderson Group
BlackRock
Suvretta Capital Management
Stifel Financial
Jupiter Topco
Woodline Partners
State Street Corporation
Infinitum Asset Management
D. E. Shaw & Co
AQR Capital Management
Geode Capital Management
FMR
Royalty Pharma Sub-Manager
Cormorant Asset Management
Goldman Sachs Group

View all funds holding Biohaven